© 2004 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2004 Oxford University Press
ARTICLE |
Factors Contributing to Mammography Failure in Women Aged 4049 Years
Affiliations of authors: Center for Health Studies, Group Health Cooperative, Seattle, WA (DSMB); Department of Epidemiology, University of Washington School of Public Health and Community Medicine, Seattle (DSMB, EW); Fred Hutchinson Cancer Research Center, Seattle (PLP, CL, EW); Department of Pathology (PLP) and Department of Radiology (CL), University of Washington School of Medicine, Seattle; Seattle Cancer Care Alliance, Seattle (CL); Applied Research Program, National Cancer Institute, National Institutes of Health, Bethesda, MD (SHT)
Correspondence to: Diana S. M. Buist, PhD, Center For Health Studies, Group Health Cooperative, 1730 Minor Ave., Ste. 1600, Seattle, WA 98101 (e-mail: buist.d{at}ghc.org)
Background: Younger women (4049 years) have lower mammographic sensitivity (i.e., greater proportion of cancers detected after a negative mammogram) than older women (
50 years). We explored the effect of tumor growth rate, breast density, mammographic image quality, and breast cancer risk factors on mammographic sensitivity in younger and older women. Methods: We studied 576 women (n = 73 aged 4049 years and n = 503 aged 50 years or older) who were diagnosed with invasive breast cancer between 1988 and 1993. Interval cancers were defined as those diagnosed within 12 or 24 months after a negative screening mammogram and before a subsequent mammogram. Tumor growth rate was assessed by mitotic figure count and Ki-67 positivity. The main outcome measures were percentage of women with interval cancer (1 mammographic sensitivity) by age, odds ratio (OR) of interval cancer by age, and excess odds (i.e., the percentage of the odds ratio for age that was explained by individual covariates). Results: Interval cancers occurred in 27.7% of younger women and 13.9% of older women within 12 months (OR = 2.36, 95% confidence interval [CI] = 1.14 to 4.77) and in 52.1% of younger women and 24.7% of older women within 24 months (OR = 3.58, 95% CI = 2.15 to 5.97). Greater breast density explained 67.6% of the decreased mammographic sensitivity in younger women at 12 months, whereas rapid tumor growth explained 30.6% and breast density explained 37.6% of the decreased sensitivity in younger women at 24 months. Conclusions: Breast density largely explained decreased mammographic sensitivity at 12 months, whereas rapid tumor growth contributed to decreased mammographic sensitivity at 24 months. A 12-month versus a 24-month mammography screening interval may therefore reduce the adverse impact of faster growing tumors on mammographic sensitivity in younger women.
Related Memo to the Media
- Press Release: Breast Density, Rapid Tumor Growth Contribute to Mammogram Failure in Women in Their Forties
- Sarah L. Zielinski
J Natl Cancer Inst 2004 96: 1407.[Extract] [Full Text]
This article has been cited by other articles:
![]() |
W. A. Berg, J. D. Blume, J. B. Cormack, E. B. Mendelson, D. Lehrer, M. Bohm-Velez, E. D. Pisano, R. A. Jong, W. P. Evans, M. J. Morton, et al. Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast Cancer JAMA, May 14, 2008; 299(18): 2151 - 2163. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Robson and K. Offit Management of an Inherited Predisposition to Breast Cancer N. Engl. J. Med., July 12, 2007; 357(2): 154 - 162. [Full Text] [PDF] |
||||
![]() |
D. L. Miglioretti and P. J. Heagerty Marginal Modeling of Nonnested Multilevel Data using Standard Software Am. J. Epidemiol., February 15, 2007; 165(4): 453 - 463. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Carney, L. A. Abraham, D. L. Miglioretti, K. R. Yabroff, E. A. Sickles, D. S. M. Buist, C. J. Kasales, B. M. Geller, R. D. Rosenberg, M. B. Dignan, et al. Factors Associated with Imaging and Procedural Events Used to Detect Breast Cancer After Screening Mammography Am. J. Roentgenol., February 1, 2007; 188(2): 385 - 392. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F. Boyd, H. Guo, L. J. Martin, L. Sun, J. Stone, E. Fishell, R. A. Jong, G. Hislop, A. Chiarelli, S. Minkin, et al. Mammographic Density and the Risk and Detection of Breast Cancer N. Engl. J. Med., January 18, 2007; 356(3): 227 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Barlow, E. White, R. Ballard-Barbash, P. M. Vacek, L. Titus-Ernstoff, P. A. Carney, J. A. Tice, D. S. M. Buist, B. M. Geller, R. Rosenberg, et al. Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst, September 6, 2006; 98(17): 1204 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Locke, Z. Kote-Jarai, E. Bancroft, S. Bullock, S. Jugurnauth, P. Osin, A. Nerurkar, L. Izatt, G. Pichert, G. P. H. Gui, et al. Loss of Heterozygosity at the BRCA1 and BRCA2 Loci Detected in Ductal Lavage Fluid from BRCA Gene Mutation Carriers and Controls. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1399 - 1402. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. McCulloch, T. Jezierski, M. Broffman, A. Hubbard, K. Turner, and T. Janecki Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers. Integr Cancer Ther, March 1, 2006; 5(1): 30 - 39. [Abstract] [PDF] |
||||
![]() |
E. D. Pisano, C. Gatsonis, E. Hendrick, M. Yaffe, J. K. Baum, S. Acharyya, E. F. Conant, L. L. Fajardo, L. Bassett, C. D'Orsi, et al. Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening N. Engl. J. Med., October 27, 2005; 353(17): 1773 - 1783. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. White, D. L. Miglioretti, B. C. Yankaskas, B. M. Geller, R. D. Rosenberg, K. Kerlikowske, L. Saba, P. M. Vacek, P. A. Carney, D. S. M. Buist, et al. Biennial Versus Annual Mammography and the Risk of Late-Stage Breast Cancer J Natl Cancer Inst, December 15, 2004; 96(24): 1832 - 1839. [Abstract] [Full Text] [PDF] |
||||
![]() |
Annual Screening Mammography for Women in Their Forties? Journal Watch Women's Health, December 8, 2004; 2004(1208): 1 - 1. [Full Text] |
||||







